Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.

MLA

Lauritano, E. C., et al. “Antibiotic Therapy in Small Intestinal Bacterial Overgrowth: Rifaximin versus Metronidazole.” European Review for Medical & Pharmacological Sciences, vol. 13, no. 2, Mar. 2009, pp. 111–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=39886245&authtype=sso&custid=ns315887.

APA

Lauritano, E. C., Gabrielli, M., Scarpellini, E., Ojetti, V., Roccarina, D., Villita, A., Fiore, F., Flore, R., Santoliquido, A., Tondi, P., Gasbarrini, G., Ghirlanda, G., & Gasbarrini, A. (2009). Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. European Review for Medical & Pharmacological Sciences, 13(2), 111–116.

Chicago

Lauritano, E. C., M. Gabrielli, E. Scarpellini, V. Ojetti, D. Roccarina, A. Villita, F. Fiore, et al. 2009. “Antibiotic Therapy in Small Intestinal Bacterial Overgrowth: Rifaximin versus Metronidazole.” European Review for Medical & Pharmacological Sciences 13 (2): 111–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=39886245&authtype=sso&custid=ns315887.